1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

A new work on a drug raising the prospect of a new life-prolonging drug – Health(Y) Destination

March 29, 2012Transplant Rejectionadmin

A new work on a drug raising the prospect of a new life-prolonging drug
Health(Y) Destination
Rapamycin is the drug that is used in widely in preventing transplant rejection and treat cancer. But the previous study of Rapamycin showed its positive effect of prolonging life time and its negative effect of causing glucose intolerance in mice, ...

and more »

Post navigation

← A voice that should be heard – Haaretz The Tylenol Liver Failure Lawyers of The Onder Law Firm Launch New No-Cost, No … – San Francisco Chronicle (press release) →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos